3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Pediatrix Medical Group's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -4.82%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Pediatrix Medical Group's 3-Year ROIIC % or its related term are showing as below:
MEX:MD's 3-Year ROIIC % is ranked worse than 62.84% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.28
vs MEX:MD: -4.82
Pediatrix Medical Group (MEX:MD) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Pediatrix Medical Group 3-Year ROIIC % Related Terms
Pediatrix Medical Group 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:MD vs SEM, AGL, SGRY: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Pediatrix Medical Group (MEX:MD) has a 3-Year ROIIC % of -4.82 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Pediatrix Medical Group and its competitors. According to the industry distribution chart, Pediatrix Medical Group ranks #389 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 62.8%.
Is Pediatrix Medical Group's 3-Year ROIIC % too high?
Pediatrix Medical Group's current 3-Year ROIIC % is -4.82. Based on the distribution chart, Pediatrix Medical Group ranks #389 out of 619 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pediatrix Medical Group has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's 3-Year ROIIC % compare to SEM and AGL?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #389 out of 619 companies for 3-Year ROIIC %. This places Pediatrix Medical Group in the lower half of its industry. The industry median 3-Year ROIIC % is 3.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.28, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current 3-Year ROIIC % is -4.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Pediatrix Medical Group (MEX:MD) has a current 3-Year ROIIC % of -4.82. The stock's GF Value™ is MXN158.60, compared to a current price of MXN323.00 — trading 103.7% above its estimated fair value. The current 3-Year ROIIC % is -4.82. Pediatrix Medical Group's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Pediatrix Medical Group (MEX:MD), the current 3-Year ROIIC % is -4.82 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (MEX:MD) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of MXN323.00 is trading 103.7% above its estimated GF Value™ of MXN158.60.
Key valuation signals for MEX:MD:
3-Year ROIIC %: -4.82
GF Value™: MXN158.60 vs. price of MXN323.00 (103.7% above fair value)
No single metric tells the full story. See the MEX:MD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
55GF Score
Get the complete analysis for MEX:MD
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MD has been successfully added to your 
